-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On December 30, Sihuan Pharmaceutical announced that its subsidiary Yaozhong International has acquired all the shares of Genesis Biosystems in the United States, further expanding the company's medical aesthetics product pipeline
Founded in 2001, Genesis is a manufacturer of high-quality aesthetics and biomedical products, mainly engaged in the development, manufacturing and distribution of beauty equipment, focusing on microchannel systems and fat collection products for cosmetic skin care treatments and plastic surgery
Genesis micro-channel system products include Derma Genesis, Dermacel and DermaFrac™, etc.
The fat collection system LipiVage is an innovative product.
In 2014, Sihuan Pharmaceutical signed an exclusive agency agreement for botulinum toxin (trade name: Le Tibold) and hyaluronic acid products with Hugel of South Korea, and since then began its layout in the field of medical aesthetics